.
Programme
![]() |
How to build knowledge about raw materials?
|
![]() |
Special materials in special products – biological excipients/raw materials in biopharmaceuticals
|
![]() |
Raw and starting materials in the ATMP arena: differences and similarities with biologicals
|
![]() |
Are Pharmacopeial Monograph Criteria Sufficient for Raw Material Specifications?
|
![]() |
EBE Concept paper on management of raw materials for biologicals
|
![]() |
Quality and regulatory aspects of biological extraction products
|
![]() |
Importance of a Quality Relationship with a Raw Material Supplier – Industrial Point of View
|
![]() |
Virus risk minimisation strategies for biopharmaceutical products
|
![]() |
Testing of Raw Materials for Herbal Medicines
|
![]() |
Detection of pyrogenic contaminations in raw materials
|
![]() |
Testing of Raw Materials - Experiences of a Contract Lab
|
![]() |
How to mitigate and control risks related to raw materials, components and excipients – case studies
|
![]() |
Interactive Discussion: Organizational cultures and strategies for microbiological control of raw materials
|
![]() |
Reduced Testing of Raw Materials and Excipients
|
![]() |
ECA’s new Guidance “Analytical Procedure Lifecycle Management” Dr Gerd Jilge, Boehringer Ingelheim, Germany |